7 completed, 2 unknown, 1 terminated. 10 Phase 3, 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 10 | Completed 7, Unknown 2, Terminated 1 |
| Phase 2 | 3 | Completed 2, Terminated 1 |
Follow Lenograstim: new trials by email Literature Review of Lenograstim trials Research Report on Lenograstim
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Trial Evaluating the Safety of 2 Schedules of Cabazitaxel in Elderly Men With mCRPC Previously Treated With a Docetaxel cabazitaxel, Prednisone, Granulocyte colony-stimulating factor (G-CSF) - Prostate Cancer Metastatic | Phase 3 | Completed | Association Pour La Recherche des Thérapeutiques Innovantes en Cancérologie | 196 | 2017-05-05 | 2022-05-12 |
| Azacytidine (Vidaza®) Versus Fludarabine and Cytarabine (Fluga Scheme) in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia Azacitadine, Fludarabine, Cytarabine - Acute Myeloid Leukemia | Phase 3 | Completed | PETHEMA Foundation | 289 | 2014-10-01 | 2020-04-06 |
| A Phase II Study Evaluating Intravenous Melphalan With Autologous Whole Blood Stem Cell Transplantation Over Three Cycles In Patients With Castration-Resistant Prostate Cancer (MEL-CAP) Melphalan, Lenograstim - Castrate Resistant Prostate Cancer | Phase 2 / Phase 3 | Terminated | Barts & The London NHS Trust | 29 | 2013-01-01 | 2023-04-19 |
| Sitagliptin Plus Granulocyte-colony Stimulating Factor in Acute Myocardial Infarction Lenograstim (GRANOCYTE)=GCSF, Sitagliptin (Januvia), Sodium Chloride (NaCl) 0.9 % - Acute Myocardial Infarction | Phase 2 / Phase 3 | Completed | Ludwig-Maximilians - University of Munich | 174 | 2008-03-01 | 2022-08-25 |
| Sequential Administration of FE75C and Docetaxel Versus Docetaxel/Cyclophosphamide in HER-2 Negative, Node Positive Breast Cancer Docetaxel, Epirubicin, Cyclophosphamide - Breast Cancer | Phase 3 | Completed | Hellenic Oncology Research Group | 650 | 2007-10-01 | 2014-05-14 |
| Dose Dense Chemotherapy + Rituximab +/-Intensified High Dose Chemoimmunotherapy With Support of Peripheral Autologous Stem Cell in Diffuse Large B-Cell Lymphoma Rituximab, Ciclofosfamide, Doxorubicina - Diffuse Large B-Cell Lymphoma, IPI≥2 | Phase 3 | Unknown | Fondazione Italiana Linfomi - ETS | 399 | 2006-01-01 | 2011-02-15 |
| Study on the Incidence of Febrile Episodes During Stem Cells Collection After Chemotherapy in Patients With Multiple Myeloma filgrastim, lenograstim - G-CSF, Multiple Myeloma, Febrile Episode, Filgrastim, Leograstim | Phase 3 | Unknown | University of Pisa | 180 | 2004-12-01 | 2009-07-03 |
| Six vs 12 Months of Trastuzumab With Docetaxel Following FEC as Adjuvant Treatment in N+ Breast Cancer Docetaxel, Trastuzumab, Epirubicin - Breast Cancer | Phase 3 | Completed | Hellenic Oncology Research Group | 489 | 2004-10-01 | 2015-03-04 |
| Randomized Phase III Trial Comparing Sequential Administration of FE75C Followed by Docetaxel Versus Paclitaxel as Adjuvant Chemotherapy in Axillary Lymph Node (+) Breast Cancer Docetaxel, Paclitaxel, Epirubicin - Breast Cancer | Phase 3 | Completed | Hellenic Oncology Research Group | 478 | 2004-08-01 | 2008-01-21 |
| Predictive Value of the "Cytocapacity Test" Patients With Lymphoproliferative Diseases and High-dose Therapy lenograstim - Hodgkin's Disease, Non-Hodgkin Lymphomas | Phase 2 / Phase 3 | Completed | WiSP Wissenschaftlicher Service Pharma GmbH | 169 | 2003-05-01 | 2010-03-11 |
Breast Neoplasms (3) · Multiple Myeloma (2) · Hodgkin Disease (1) · Leukemia, Myeloid, Acute (1) · Lymphoma, Large B-Cell, Diffuse (1) · Myocardial Infarction (1)
Hellenic Oncology Research Group (3) · Association Pour La Recherche des Thérapeutiques Innovantes en Cancérologie (1) · Barts & The London NHS Trust (1) · Fondazione Italiana Linfomi - ETS (1) · Ludwig-Maximilians - University of Munich (1) · PETHEMA Foundation (1) · University of Pisa (1) · WiSP Wissenschaftlicher Service Pharma GmbH (1)
Greece (3) · Germany (2) · France (1) · Italy (1) · Spain (1) · United Kingdom (1)
Dimitris Mavrudis, MD (3) · Jonathan Shamash, MD FRCP (1) · Pau Montesinos, Dr (1) · Umberto Vitolo, MD (1) · Wolfgang M Franz, Prof. Dr. (1)
PMID 21163927, PMID 26709136, PMID 27502729, PMID 28668386, PMID 32817282, PMID 33463373, PMID 34070172, PMID 37883073, PMID 42020286